Cover image of the article: Antihypertensive effects of some new nitroxyalkyl 1,4-dihydropyridine derivatives in rat model of two-kidney, one-clip hypertension

Image Credit:Iran J Pharm Res

Antihypertensive effects of some new nitroxyalkyl 1,4-dihydropyridine derivatives in rat model of two-kidney, one-clip hypertension

Authors

Ali Akbar Nekooeian1, Azadeh Khalili1, Katayoun Javidnia2, 3, Ahmad Reza Mehdipour2, Ramin Miri2, 3,*
1Department of Pharmacology, Faculty of Medicine, Shiraz University of Medical Science, Shiraz, Iran
2Medicinal & Natural Products Chemistry Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran
3Department of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
*Corresponding Author: Medicinal & Natural Products Chemistry Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran. Email:mirir@sums.ac.ir

Iranian Journal of Pharmaceutical Research:Vol. 8, issue 3; 193-199
Published online:Nov 20, 2010
Article type:Research Article
Received:Oct 01, 2008
Accepted:Feb 01, 2009
How to Cite:Nekooeian AA, Khalili A, Javidnia K, Mehdipour AR, Miri R. Antihypertensive effects of some new nitroxyalkyl 1,4-dihydropyridine derivatives in rat model of two-kidney, one-clip hypertension. Iran J Pharm Res. 2022;8(3):e128637. doi: https://doi.org/10.22037/ijpr.2010.810

Abstract

Dihydropyridine calcium channel blockers consist one of the widely-used groups of drugs for the management of hypertension. In this study, antihypertensive effects of 5 newly synthesized derivatives of DHP was examined the in rat model of two-kidney, one-clip renal hypertension. The results showed that those compounds containing two nitroxy groups had less decreasing effect on MAP (Men Arterial Pressure) compared to those having one nitroxy group in 5 position. On the other hand, conformational analysis indicated that in two compounds with two chains (A and E), a great steric hindrance existed; therefore, steric hindrance is the most important factor for interaction of compounds with their receptors.

Highlights

Copyright

© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

20
Nov
2010
Synthesis and Biological Evaluation of New 1, 4-Dihydropyridines as Antihypertensives Agents in Rats

Synthesis and Biological Evaluation of New 1, 4-Dihydropyridines as Antihypertensives Agents in Rats

Masoumeh Jorjani,
Hossein Rastegar,
Farshad Roshanzamir,
Mehdí Varmazyari,
Mohammad Abdollahi,
Afshin Zarghi

Jorjani M, Rastegar H, Roshanzamir F, Varmazyari M, Abdollahi M, et al. Synthesis and Biological Evaluation of New 1, 4-Dihydropyridines as Antihypertensives Agents in Rats. Iran J Pharm Res. 2022;2(1):e127608. doi: https://doi.org/10.22037/ijpr.2010.34

31
Oct
2016
Synthesis and Biological Evaluation of New Tricyclic Dihydropyridine Based Derivatives on Potassium Channels

Synthesis and Biological Evaluation of New Tricyclic Dihydropyridine Based Derivatives on Potassium Channels

Miyase Gözde Gündüz,
Yesim Kaya,
Rahime Şimşek,
Inci Sahin-Erdemli,
Cihat Şafak

Gündüz MG, Kaya Y, Şimşek R, Sahin-Erdemli I, Şafak C. Synthesis and Biological Evaluation of New Tricyclic Dihydropyridine Based Derivatives on Potassium Channels. Iran J Pharm Res. 2016;15(4):e125238. doi: https://doi.org/10.22037/ijpr.2016.1928

31
Oct
2015
Design, Synthesis and Biological Evaluation of New 1,
4-Dihydropyridine (DHP) Derivatives as Selective Cyclooxygenase-2
Inhibitors

Design, Synthesis and Biological Evaluation of New 1, 4-Dihydropyridine (DHP) Derivatives as Selective Cyclooxygenase-2 Inhibitors

Iman Sabakhi,
Vigen Topuzyan,
Zahra Hajimahdi,
Bahram Daraei,
Hadi Arefi,
Afshin Zarghi

Sabakhi I, Topuzyan V, Hajimahdi Z, Daraei B, Arefi H, et al. Design, Synthesis and Biological Evaluation of New 1, 4-Dihydropyridine (DHP) Derivatives as Selective Cyclooxygenase-2 Inhibitors. Iran J Pharm Res. 2015;14(4):e125380. doi: https://doi.org/10.22037/ijpr.2015.1727

31
Jul
2011
Cytotoxic Effect of Some 1, 4-Dihydropyridine Derivatives Containing Nitroimidazole Moiety

Cytotoxic Effect of Some 1, 4-Dihydropyridine Derivatives Containing Nitroimidazole Moiety

Ramin Miri,
Katayoun Javidnia,
Zahra Amirghofran,
Seyyed Hossein Salimi,
Zahra Sabetghadam,
Savis Meili
,et al.

Miri R, Javidnia K, Amirghofran Z, Salimi SH, Sabetghadam Z, et al. Cytotoxic Effect of Some 1, 4-Dihydropyridine Derivatives Containing Nitroimidazole Moiety. Iran J Pharm Res. 2011;10(3):e125957. doi: https://doi.org/10.22037/ijpr.2011.991

31
Jul
2016
Assessment of the Cytotoxic Effect of a Series of 1,4-Dihydropyridine Derivatives Against Human Cancer Cells

Assessment of the Cytotoxic Effect of a Series of 1,4-Dihydropyridine Derivatives Against Human Cancer Cells

Nima Razzaghi-Asl,
Ramin Miri,
Omidreza Firuzi

Razzaghi-Asl N, Miri R, Firuzi O. Assessment of the Cytotoxic Effect of a Series of 1,4-Dihydropyridine Derivatives Against Human Cancer Cells. Iran J Pharm Res. 2016;15(3):e125157. doi: https://doi.org/10.22037/ijpr.2016.1870

More by these authors

Ali Akbar NekooeianPubMedScholar
Azadeh KhaliliPubMedScholar
Katayoun JavidniaPubMedScholar
Ahmad Reza MehdipourPubMedScholar
Ramin MiriPubMedScholar
Share
Cited by
Metrics